Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Clinical trial NCT07309432 · RECRUITING
Trial details
- NCT number
- NCT07309432
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-10
- Primary completion
- 2027-02-28
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.